Search - tctmd.com

Displaying 21 - 40 of 7406

Sort: Relevancy | Date

News Conference News AHA 2025

One Month of Dual Antithrombotic Therapy May Be Enough After PCI in AF Patients

Todd Neale

November 08, 2025

News Conference News TCT 2025

At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I

Yael L. Maxwell

November 07, 2025

News Conference News TCT 2025

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

Todd Neale

November 03, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2025

Caitlin E. Cox

November 03, 2025

News Industry News

SMT’s Supraflex Cruz Shows Consistent and Robust Clinical Outcomes Across Key Global Studies Presented at TCT 2025

October 29, 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen Over Time

News Conference News TCT 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Michael O'Riordan

October 29, 2025

News Conference News TCT 2025

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

Yael L. Maxwell

October 28, 2025

News Conference News TCT 2025

PROCTOR: PCI of Failed Bypass Grafts Tops Native-Vessel PCI, With Caveats

Todd Neale

October 28, 2025

News Conference News TCT 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Michael O'Riordan

October 28, 2025

Presentation TCT 2025

Two Stents at the Bifurcation: Tailoring Your Technique

Presenter: Kefei Dou

October 28, 2025

Presentation TCT 2025

Provisional Left Main Stenting: Contemporary Considerations

Presenter: Duk-Woo Park

October 28, 2025

Presentation TCT 2025

Randomized Comparison of the Supraflex CruzTM vs. SYNERGYTM Drug-Eluting Stents: The Multivessel TALENT Randomized Trial

Presenter: Patrick W. Serruys

October 28, 2025

Presentation TCT 2025

TCT 513: Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Treatment for Single De Novo Diffuse Coronary Lesions

Presenter: Eun-Seok Shin

October 28, 2025

Presentation TCT 2025

TCT 1271: Safety and Efficacy of Biodegradable Polymer-coated Sirolimus-eluting Stent in the Treatment of Octo- and Nonagenarian All Comer Patients with Coronary Artery Disease – Results from the Prospective Multicenter Cruz Senior Study

Presenter: Gregor Nelles

October 28, 2025

Presentation TCT 2025

TCT 243: Innovative Iron-based Biodegradable Metal Coronary Stent

Presenter: Jian Xie

October 28, 2025

Presentation TCT 2025

TCT 963: Ethnic Disparities in Inflammatory Phenotype and CV Outcomes After Drug-Eluting Stent Implantation: A Multiethnic Perspective

Presenter: Kyung-Taek Park

October 28, 2025

Presentation TCT 2025

TCT 245: Final 7-Year Results from the COMPARE-ABSORB Trial: Randomized Comparison of Bioresorbable Vascular Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis. Detailed analysis of long lesions

Presenter: Robert-Jan Van Geuns

October 28, 2025

Presentation TCT 2025

TCT 244: Biodegradable Coronary Stent

Presenter: Ryan Bruni

October 28, 2025

Presentation TCT 2025

TCT 619: Validation of Novel Endpoint for Optimal Drug-eluting stent Implantation in Patients with Acute Coronary Syndrome

Presenter: Hisaki Masuda

October 28, 2025

Presentation TCT 2025

TCT 1957: Improved Outcomes for In-Stent Restenosis PCI With Use of Sirolimus Eluting Ultra-thin Stent Platform

Presenter: Jared Romeo

October 28, 2025

Advertisement

One Month of Dual Antithrombotic Therapy May Be Enough After PCI in AF Patients

At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

TCTMD’s Top 10 Most Popular Stories for October 2025

SMT’s Supraflex Cruz Shows Consistent and Robust Clinical Outcomes Across Key Global Studies Presented at TCT 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

PROCTOR: PCI of Failed Bypass Grafts Tops Native-Vessel PCI, With Caveats

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Two Stents at the Bifurcation: Tailoring Your Technique

Provisional Left Main Stenting: Contemporary Considerations

Randomized Comparison of the Supraflex CruzTM vs. SYNERGYTM Drug-Eluting Stents: The Multivessel TALENT Randomized Trial

TCT 513: Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Treatment for Single De Novo Diffuse Coronary Lesions

TCT 1271: Safety and Efficacy of Biodegradable Polymer-coated Sirolimus-eluting Stent in the Treatment of Octo- and Nonagenarian All Comer Patients with Coronary Artery Disease – Results from the Prospective Multicenter Cruz Senior Study

TCT 243: Innovative Iron-based Biodegradable Metal Coronary Stent

TCT 963: Ethnic Disparities in Inflammatory Phenotype and CV Outcomes After Drug-Eluting Stent Implantation: A Multiethnic Perspective

TCT 245: Final 7-Year Results from the COMPARE-ABSORB Trial: Randomized Comparison of Bioresorbable Vascular Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis. Detailed analysis of long lesions

TCT 244: Biodegradable Coronary Stent

TCT 619: Validation of Novel Endpoint for Optimal Drug-eluting stent Implantation in Patients with Acute Coronary Syndrome

TCT 1957: Improved Outcomes for In-Stent Restenosis PCI With Use of Sirolimus Eluting Ultra-thin Stent Platform

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content